LINCO-SPECTIN 100, 222/444.7 MG/G POWDER FOR USE IN DRINKING WATER FOR PIGS AND CHICKENS

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Koop het nu

Download Productkenmerken (SPC)
12-06-2017

Werkstoffen:

SPECTINOMYCIN (AS SPECTINOMYCIN SULPHATE PH.EUR.), LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Beschikbaar vanaf:

Zoetis Ireland Limited

ATC-code:

QJ01FF52

INN (Algemene Internationale Benaming):

SPECTINOMYCIN (AS SPECTINOMYCIN SULPHATE PH.EUR.), LINCOMYCIN (AS LINCOMYCIN HYDROCHLORIDE PH. EUR.)

Dosering:

222/444.7

farmaceutische vorm:

Powder for Oral Solution

Prescription-type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutische categorie:

Fowl - Chicken, Porcine

Therapeutisch gebied:

lincomycin, combinations

therapeutische indicaties:

Antibacterial

Autorisatie-status:

Authorised

Autorisatie datum:

2015-02-06

Productkenmerken

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Linco-Spectin 100, 222/444.7 mg/g Powder for use in drinking water for
pigs and chickens
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCES:
Lincomycin (as lincomycin hydrochloride)
222 mg
Spectinomycin (as spectinomycin sulphate)
444.7 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
White pale powder for use in drinking water.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs and chickens.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs
For the treatment and metaphylaxis of porcine proliferative
enteropathy (ileitis) caused by_ Lawsonia intracellularis_,
and associated enteric pathogens (_Escherichia coli_) susceptible to
lincomycin and spectinomycin.
The presence of the disease in the group must be established before
the product is used.
Chickens
For the treatment and metaphylaxis of chronic respiratory disease
(CRD) caused by_ Mycoplasma gallisepticum_ and
_Escherichia coli_ susceptible to lincomycin and spectinomycin, and
associated with a low mortality rate.
The presence of the disease in the flock must be established before
the product is used.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or any
of the excipients.
Do not use in case of hepatic dysfunction.
Do not allow rabbits, rodents (e.g. chinchillas, hamsters, guinea
pigs), horses or ruminants to access to water or feeds
containing lincomycin. Ingestion by these species may result in severe
gastrointestinal effects.
Do not use in laying hens.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
                                
                                Lees het volledige document
                                
                            

Zoekwaarschuwingen met betrekking tot dit product